Bioventix (GB:BVXP) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Bioventix PLC’s Chief Financial Officer, Bruce Hiscock, has increased his stake in the company by purchasing 24 ordinary shares at an average price of 3,822 pence per share through a dividend reinvestment plan. This acquisition brings his total beneficial interest to 1,113 shares, representing a modest 0.02% of the company’s issued share capital. Such insider transactions can often be a point of interest for investors looking for signals of confidence in the company’s future performance.
For further insights into GB:BVXP stock, check out TipRanks’ Stock Analysis page.